These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22464953)

  • 1. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Alzheimer's disease therapeutics.
    Rafii MS
    J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease.
    Zhang RY; Leon AC; Chuang-Stein C; Romano SJ
    Clin Trials; 2011 Feb; 8(1):5-14. PubMed ID: 21335586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
    Yaffe K; Tocco M; Petersen RC; Sigler C; Burns LC; Cornelius C; Khachaturian AS; Irizarry MC; Carrillo MC
    Alzheimers Dement; 2012 May; 8(3):237-42. PubMed ID: 22546356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Ankarcrona M; Mangialasche F; Winblad B
    J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical trials in Alzheimer's disease: selection and evaluation of drug candidates.
    Reines SA
    Prog Clin Biol Res; 1989; 317():1283-90. PubMed ID: 2690095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.
    Flood DG; Marek GJ; Williams M
    Biochem Pharmacol; 2011 Jun; 81(12):1422-34. PubMed ID: 21295552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development.
    Mhillaj E; Cuomo V; Mancuso C
    Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):95-111. PubMed ID: 28177983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease.
    Munoz L; Ammit AJ
    Neuropharmacology; 2010 Mar; 58(3):561-8. PubMed ID: 19951717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When will Alzheimer's disease be cured? A pharmaceutical perspective.
    Townsend M
    J Alzheimers Dis; 2011; 24 Suppl 2():43-52. PubMed ID: 21368375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in Alzheimer's disease drug development.
    Cummings JL
    Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxibs and Alzheimer's disease: should they stay or should they go?
    Firuzi O; Praticò D
    Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
    Arendash GW
    J Alzheimers Dis; 2012; 32(2):243-66. PubMed ID: 22810103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.